Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Human T cells can be directed to lyse tumor targets through the alternative activation/T11-E rosette receptor pathway.

Human T cells can be directed to lyse tumor targets through the alternative activation/T11-E rosette receptor pathway. J Immunol. 1988 Jan 01; 140(1):8-14.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.